Sat, Dec 20, 2014, 6:51 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Synergy Pharmaceuticals, Inc. Message Board

  • ding_king2000 ding_king2000 Nov 14, 2013 5:25 PM Flag

    NOW THIS IS A LIE: Aegis reiterated it's 'buy' rating on SGYP today and maintains its $23.. THIS IS OVER 18 MONTHS OLD!!


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Just when I thought you had a little bit of smarts about you prove me wrong....this rating is better and means more than it did when it was first issued....would have been no shame for Aegis to have backed down on its price projection and/or rating but it was maintained. No one had a gun to Ram's head...he weighed the evidence and determined he didn't need to revise a thing...personally, I'd rather that than a 'just announced' upgrade.

    • Aegis Reiterates Buy Rating for Synergy Pharmaceuticals (SGYP)
      WKRB News-Nov 13, 2013
      Synergy Pharmaceuticals Inc. logo Synergy Pharmaceuticals (NASDAQ:SGYP)'s stock had its “buy” ...
      UPDATE: Aegis Capital Reiterates on Synergy Pharmaceuticals on ...
      Benzinga-Nov 13, 2013
      In a report published Wednesday, Aegis Capital analyst Raghuram Selvaraju reiterated a Buy rating ...
      Analysts' Ratings Reiterations for November, 13th (AEGR, BAA, BG ...
      Zolmax-Nov 13, 2013
      Synergy Pharmaceuticals (NASDAQ:SGYP) had its buy rating reiterated by analysts at Aegis. Aegis ...

3.27+0.22(+7.21%)Dec 19 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.